» Articles » PMID: 19428722

Engineered Affinity Proteins--generation and Applications

Overview
Journal J Biotechnol
Date 2009 May 12
PMID 19428722
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The use of combinatorial protein engineering to design proteins with novel binding specificities and desired properties has evolved into a powerful technology, resulting in the recent advances in protein library selection strategies and the emerge of a variety of new engineered affinity proteins. The need for different protein library selection methods is due to that each target protein pose different challenges in terms of its availability and inherent properties. At present, alternative engineered affinity proteins are starting to complement and even challenge the classical immunoglobulins in different applications in biotechnology and potentially also for in vivo use as imaging agents or as biotherapeutics. This review article covers the generation and use of affinity proteins generated through combinatorial protein engineering. The most commonly used selection techniques for isolation of desired variants from large protein libraries are described. Different antibody derivatives, as well as a variety of the most validated engineered protein scaffolds, are discussed. In addition, we provide an overview of some of the major present and future applications for these engineered affinity proteins in biotechnology and medicine.

Citing Articles

SAAMBE-MEM: a sequence-based method for predicting binding free energy change upon mutation in membrane protein-protein complexes.

Rimal P, Panday S, Xu W, Peng Y, Alexov E Bioinformatics. 2024; 40(9).

PMID: 39240325 PMC: 11407696. DOI: 10.1093/bioinformatics/btae544.


Generation of human TMEM16F-specific affibodies using purified TMEM16F.

Kim E, Bang J, Sung J, Lee J, Shin D, Kim S Front Mol Biosci. 2024; 10:1319251.

PMID: 38274091 PMC: 10808743. DOI: 10.3389/fmolb.2023.1319251.


Modular Synthesis of Semiconducting Graft Copolymers to Achieve "Clickable" Fluorescent Nanoparticles with Long Circulation and Specific Cancer Targeting.

Creamer A, Fiego A, Agliano A, Prados-Martin L, Hogset H, Najer A Adv Mater. 2023; 36(20):e2300413.

PMID: 36905683 PMC: 7616993. DOI: 10.1002/adma.202300413.


Design of an artificial phage-display library based on a new scaffold improved for average stability of the randomized proteins.

Gomes M, Fleck A, Degaugue A, Gourmelon F, Leger C, Aumont-Nicaise M Sci Rep. 2023; 13(1):1339.

PMID: 36693880 PMC: 9873692. DOI: 10.1038/s41598-023-27710-4.


Anticalin N- or C-Terminal on a Monoclonal Antibody Affects Both Production and In Vitro Functionality.

Aubrey N, Gouilleux-Gruart V, Dhommee C, Mariot J, Boursin F, Albrecht N Antibodies (Basel). 2022; 11(3).

PMID: 35997348 PMC: 9397084. DOI: 10.3390/antib11030054.